Literature DB >> 29774315

Retrospective Analysis of Patients with Synchronous Primary Breast and Thyroid Carcinoma.

İlker Murat Arer1, Hakan Yabanoğlu1, Murat Kuş1, Aydıncan Akdur2, Tevfik Avcı2.   

Abstract

OBJECTIVE: Breast and thyroid cancers are commonly encountered malignancies. Increased risk of breast cancer in follow-up period of thyroid cancer or vice versa has been reported. However, they have some associations, synchronous presentation of these tumors is rare. We presented 12 patients diagnosed as breast and thyroid cancer and treated at the same time.
MATERIALS AND METHODS: Mastectomy and thyroidectomy were performed in 19 patients at the same time. 7 patients were excluded because of benign thyroid pathology. Therefore 12 patients who had diagnosis of synchronous breast and thyroid cancer were included. Data regarding clinical, pathological, treatment and prognostic factors was retrospectively analyzed.
RESULTS: Total thyroidectomy was performed in all patients. The mean age of patients was 54 years (min. 44-max. 70). Only one patient was male. Thyroid pathology was detected preoperatively by FDG PET-CT scan in 11 patients. Breast reconstruction was performed in three patients. The most commonly seen thyroid malignancy was papillary thyroid carcinoma. Postoperative complication rate was 33.3%. Adjuvant chemotherapy was given in 11 patients whereas one patient received adjuvant radiotherapy.
CONCLUSION: Although synchronous presentation of breast and thyroid cancer is rare, surgical treatment of both of these tumors can be safely performed at the same time. Association of these tumors should be evaluated by large scaled studies.

Entities:  

Keywords:  Breast cancer; mastectomy; synchronous cancer; thyroid cancer; thyroidectomy

Year:  2018        PMID: 29774315      PMCID: PMC5939983          DOI: 10.5152/ejbh.2018.3853

Source DB:  PubMed          Journal:  Eur J Breast Health


  29 in total

1.  Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study.

Authors:  Jasmine Brandt; Signe Borgquist; Jonas Manjer
Journal:  Cancer Causes Control       Date:  2015-06-02       Impact factor: 2.506

2.  Benign thyroid disease is associated with breast cancer: a meta-analysis.

Authors:  Prue J Hardefeldt; Guy D Eslick; Senarath Edirimanne
Journal:  Breast Cancer Res Treat       Date:  2012-03-21       Impact factor: 4.872

3.  Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.

Authors:  Wakako Kawabata; Takashi Suzuki; Takuya Moriya; Keisei Fujimori; Hiroshi Naganuma; Satoshi Inoue; Yositaka Kinouchi; Kaori Kameyama; Hiroshi Takami; Tooru Shimosegawa; Hironobu Sasano
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

4.  Second primary cancers in thyroid cancer patients: a multinational record linkage study.

Authors:  Thekkepat C Sandeep; Mark W J Strachan; Rebecca M Reynolds; David H Brewster; Ghislaine Scélo; Eero Pukkala; Kari Hemminki; Aage Anderson; Elizabeth Tracey; Søren Friis; Mary L McBride; Chia Kee-Seng; Vera Pompe-Kirn; Erich V Kliewer; Jon M Tonita; Jon G Jonasson; Carmen Martos; Paolo Boffetta; Paul Brennan
Journal:  J Clin Endocrinol Metab       Date:  2006-02-14       Impact factor: 5.958

Review 5.  Second cancers in survivors of childhood cancer.

Authors:  Smita Bhatia; Charles Sklar
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

6.  Effects of thyroid hormones on human breast cancer cell proliferation.

Authors:  Linda C Hall; Eddie P Salazar; Staci R Kane; Nan Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2007-12-07       Impact factor: 4.292

7.  Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective study.

Authors:  S Johansen; K V Reinertsen; K Knutstad; D R Olsen; S D Fosså
Journal:  Radiat Oncol       Date:  2011-06-09       Impact factor: 3.481

8.  Breast cancer in association with thyroid disorders.

Authors:  Orhan Turken; Yavuz NarIn; Sezai DemIrbas; M Emin Onde; Ozkan Sayan; E Gokhan KandemIr; Mustafa YaylacI; Ahmet Ozturk
Journal:  Breast Cancer Res       Date:  2003-06-05       Impact factor: 6.466

9.  Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population.

Authors:  Yaqin Ling; Xiaoling Ling; Lu Fan; Yong Wang; Qing Li
Journal:  Onco Targets Ther       Date:  2015-10-16       Impact factor: 4.147

10.  Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.

Authors:  Raffaella Marcheselli; Luigi Marcheselli; Laura Cortesi; Alessia Bari; Claudia Cirilli; Samantha Pozzi; Paola Ferri; Martina Napolitano; Massimo Federico; Stefano Sacchi
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

View more
  3 in total

1.  Diagnostic Performance of F18-FDG PET/CT in Male Breast Cancers Patients.

Authors:  Andra Piciu; Doina Piciu; Narcis Polocoser; Anita A Kovendi; Iulia Almasan; Alexandru Mester; Dragos-Stefan Morariu; Calin Cainap; Simona Sorana Cainap
Journal:  Diagnostics (Basel)       Date:  2021-01-13

2.  Synchronous papillary thyroid carcinoma and breast ductal carcinoma.

Authors:  Heng Kong; JiXin Chen; Shou-Ching Tang
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

3.  Correlation Analysis of Breast and Thyroid Nodules: A Cross-Sectional Study.

Authors:  Jingtai Chen; Zhou Xu; Lingmi Hou; Yunhui Tang; Shuangqiang Qian; Hongyu Pu; Juan Tang; Yanchun Gao
Journal:  Int J Gen Med       Date:  2021-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.